{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T15:16:06Z","timestamp":1721920566158},"reference-count":33,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Review of Neurotherapeutics"],"published-print":{"date-parts":[[2004,3]]},"DOI":"10.1586\/14737175.4.2.191","type":"journal-article","created":{"date-parts":[[2005,1,13]],"date-time":"2005-01-13T11:03:17Z","timestamp":1105614197000},"page":"191-198","source":"Crossref","is-referenced-by-count":9,"title":["Paroxetine in panic disorder: clinical management and long-term follow-up"],"prefix":"10.1586","volume":"4","author":[{"given":"Pinhas N","family":"Dannon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Lowengrub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Iancu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moshe","family":"Kotler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,1,10]]},"reference":[{"key":"CIT0001","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Dismrlers. Fourth Edition. American Psychiatric Association Inc. Washington DC, USA (1994)."},{"key":"CIT0002","first-page":"22","volume":"40","author":"Dyckman JM","year":"1999","journal-title":"Bychosomatics"},{"key":"CIT0008","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1997.01830160021003"},{"issue":"283","key":"CIT0011","first-page":"2529","volume":"4","author":"Barlow DH","year":"2000","journal-title":"JA M"},{"key":"CIT0014","unstructured":"Sheehan DV. The treatment of panic and phobic disorders. In: Clinical Bychopharmacology Second Edition. Bernstein JC (Ed.). John Wright-PSG, MA, USA (1984)."},{"key":"CIT0015","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1988.01800290027004"},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.144.3.303"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.12.1989"},{"issue":"3","key":"CIT0018","first-page":"163","volume":"106","author":"Bakker A","year":"2002","journal-title":"Scand"},{"key":"CIT0019","unstructured":"Keltner NL, Folks DG. PTchotropic Drug. Second Edition. Mosby-Year Book Inc. PA, USA (1997)."},{"issue":"1","key":"CIT0021","first-page":"53","volume":"37","author":"Pollack MET","year":"2003","journal-title":"Psychopharmacol Bull"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.167.3.374"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n1205"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1997.tb00388.x"},{"key":"CIT0030","first-page":"153","volume":"95","author":"Lecrubier Y","year":"1997","journal-title":"Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Acta Bychiatr. Scand"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(01)00359-7"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.3109\/10401230109148949"},{"key":"CIT0037","unstructured":"Physicians Desk Reference. 56th Edition. Medical Economics Co. NJ, USA (2002)."},{"issue":"279","key":"CIT0038","first-page":"609","volume":"4","author":"Kuhn NA","year":"1998","journal-title":"JA\/V\/"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1080\/080352501300067596"},{"key":"CIT0040","first-page":"828","volume":"61","author":"Misri S","year":"2000","journal-title":"Paroxetine levels in postpartum depressed women, breast milk and infant serum. J. Clin. Psych"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.2.185"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n0414"},{"issue":"4","key":"CIT0044","first-page":"755","volume":"33","author":"Zajecka J","year":"1997","journal-title":"Psychopharmacol Buff"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v61n0406"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1994.03950050015002"},{"issue":"8","key":"CIT0049","first-page":"708","volume":"280","author":"Stein MB","year":"1998","journal-title":"JA\/V\/A"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.58.7.681"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.1177\/02698811030173009"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(93)90021-S"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1037\/0022-006X.67.4.583"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1016\/0005-7967(93)90026-Q"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1007\/s002130000372"}],"container-title":["Expert Review of Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1586\/14737175.4.2.191","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,1,31]],"date-time":"2017-01-31T01:48:31Z","timestamp":1485827311000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1586\/14737175.4.2.191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,3]]},"references-count":33,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,1,10]]},"published-print":{"date-parts":[[2004,3]]}},"alternative-id":["10.1586\/14737175.4.2.191"],"URL":"https:\/\/doi.org\/10.1586\/14737175.4.2.191","relation":{},"ISSN":["1473-7175","1744-8360"],"issn-type":[{"value":"1473-7175","type":"print"},{"value":"1744-8360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,3]]}}}